{"issuance_frequency":"","notes_translated":{"fr":"Santé Canada continuera également d'explorer et d'acquérir des traitements et des produits thérapeutiques contre la COVID-19, d'accélérer les examens réglementaires des médicaments, des instruments médicaux et des désinfectants, d'acquérir de l'équipement médical et de protection personnelle nécessaire, d'accorder la priorité à l'examen des tests de dépistage de la COVID-19, y compris les nouvelles options et technologies novatrices, et de poursuivre les stratégies visant à accroître la capacité en dépistage.","en":"Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical devices and disinfectants; procure any needed medical and personal protective equipment; prioritize the review of COVID-19 tests, including new, innovative options and technologies; and pursue strategies to expand testing capacity."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"3530faba-311f-4a43-a19d-35ae82d7c942","metadata_created":"2021-05-28T17:31:03.848911","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-05-28T17:31:03.848917","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-05-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Santé Canada","plan ministériel","plan ministériel 2021–22","traitements COVID-19","thérapies","tests COVID-19","capacité d'analyse","accélération des examens réglementaires","médicaments","dispositifs médicaux","désinfectants","équipements de protection individuelle"],"en":["Health Canada","departmental plan","departmental plan 2021–22","COVID-19 treatments","therapies","COVID-19 tests","testing capacity","expedite regulatory reviews","drugs","medical devices","disinfectants","personal protective equipments"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"2021–2022 Plan ministériel : Santé Canada","en":"2021–22 Departmental Plan: Health Canada"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"3530faba-311f-4a43-a19d-35ae82d7c942","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"eadf09e5-3c9c-43e0-a18d-c7d22ba80b13","related_relationship":"","name_translated":{"fr":"2021–2022 Plan ministériel : Santé Canada","en":"2021–22 Departmental Plan: Health Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"2021–22 Departmental Plan: Health Canada","language":["en"],"created":"2021-05-28T17:31:03.929405","url":"https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/report-plans-priorities/2021-2022-report-plans-priorities.html","last_modified":null,"position":0,"revision_id":"7d95ee80-6509-4fb4-8811-305e8095b058","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"3530faba-311f-4a43-a19d-35ae82d7c942","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ab6bbb55-2686-45ff-9227-85cb3f6c8001","related_relationship":"","name_translated":{"fr":"2021–2022 Plan ministériel : Santé Canada","en":"2021–22 Departmental Plan: Health Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"2021–22 Departmental Plan: Health Canada","language":["fr"],"created":"2021-05-28T17:31:03.929411","url":"https://www.canada.ca/fr/sante-canada/organisation/transparence/rapports-gestion/rapport-plans-priorites/2021-2022-rapport-plans-priorites.html","last_modified":null,"position":1,"revision_id":"7d95ee80-6509-4fb4-8811-305e8095b058","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-02-16 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"3530faba-311f-4a43-a19d-35ae82d7c942","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical devices and disinfectants; procure any needed medical and personal protective equipment; prioritize the review of COVID-19 tests, including new, innovative options and technologies; and pursue strategies to expand testing capacity.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"2021–22 Departmental Plan: Health Canada","revision_id":"7d95ee80-6509-4fb4-8811-305e8095b058"}